Simultaneous MLPA-based multiplex point mutation and deletion analysis of the dystrophin gene.
The Multiplex Ligation-dependent Probe Amplification assay (MLPA) is the method of choice for the initial mutation screen in the analysis of a large number of genes where partial or total gene deletion is part of the mutation spectrum. Although MLPA dosage probes are usually designed to bind to norm...
Autors principals: | Bunyan, D, Skinner, A, Ashton, E, Sillibourne, J, Brown, T, Collins, A, Cross, N, Harvey, J, Robinson, DO |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2007
|
Ítems similars
-
A new approach for the identification of common point mutations within the dystrophin gene using MLPA
per: Skinner, A, et al.
Publicat: (2005) -
MLPA-based point mutation analysis of the FBN1 gene in Marfan syndrome patients.
per: Bunyan, D, et al.
Publicat: (2004) -
MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
per: Sekar Deepha, et al.
Publicat: (2017-06-01) -
Characterisation of beta globin gene cluster deletions using multiplex-Gap-PCR and Multiplex Ligation-dependent Probe Amplification (MLPA)
per: Redzuwan, Yasmin Mohamad
Publicat: (2018) -
Revisiting and updating molecular epidemiology of α-thalassemia mutations in Thailand using MLPA and new multiplex gap-PCR for nine α-thalassemia deletion
per: Wittaya Jomoui, et al.
Publicat: (2023-06-01)